Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

The conclusion is that self-concept, shame, and emotion regulation are key factors in hoarding disorder, body dysmorphic disorder, and trichotillomania, and should be targeted in treatment and research.

Effective symptom management in IBD improves quality of life and prevents complications.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.

New drug uses show promise but need more research.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

The document suggests that finasteride may cause depression and suicidal thoughts, while prostate surgery does not harm sexual health.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Consider benefits and risks of new alopecia treatments for safety.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Higher cholesterol levels increase aggressive prostate cancer risk.

Pegvaliase is recommended for treating adults with phenylketonuria.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Researchers found that certain lipids, especially vitamin D3, are lower in prematurely grey hair than in pigmented hair.

Men with moderate hair loss had the best spatial thinking, and long-term DHT might affect cognition.

Trichotillomania may have a genetic link to psychiatric disorders.

Alopecia areata negatively affects self-esteem, relationships, and academics in young people.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Hair loss can cause significant social and emotional issues, especially for women and young men.

Women with PCOS tend to be less optimistic than those without it.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Post-finasteride syndrome's existence is uncertain; more research needed.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

Finasteride may help reduce tic severity in male Tourette syndrome patients.